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Received 3 February 2014; revised 3 March 2014; accepted 11 March 2014AbstractBackground: The aim of this study was to compare 6 weeks short-term moderate intensity aerobic exercise and dieting on serum metabolomics
and cardio-metabolic risk factors in pre-menopausal women.
Methods: Ninety previously inactive overweight and obese (BMI 25e35 kg/m2) women (age 41.5  7.6 years) were randomized to either a
6-week Nordic walking exercise program (EX, n ¼ 45) or dietary counseling group (DI, n ¼ 45). Body composition, serum glucose, insulin and
lipids were measured. Serum low-molecular-weight metabolites and lipid constituents were analyzed by nuclear magnetic resonance spec-
troscopy. Measurements were done at baseline and 7 days after the last training session.
Results: Six weeks aerobic exercise program yielded reductions in serum free fatty acids (34.7%, 95% confidence interval (CI), 50 to 18,
p < 0.001), glucose (9.6%, 95%CI, 15 to 4, p < 0.001) and homeostasis model assessment of insulin resistance (HOMA-IR) (28.7%,
95%CI, 48 to 10, p ¼ 0.005) without changes in body weight or fat mass. Diet counseling resulted in loss of body weight (1.5%, 95%CI,
2.3 to 0.7, p ¼ 0.001) but no changes in free fatty acids, fasting glucose, or HOMA-IR were found.
Conclusion: Our results indicate that small weight loss does not produce measurable health benefits, whereas short-term regular aerobic exercise
can improve glucose and lipid metabolism even in the absence of weight loss in previously sedentary overweight and obese women.
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The modern way of life, characterized by abundance of
energy-enriched foods coupled with sedentary lifestyles is
associated with increased obesity and cardiovascular disease
(CVD).1 Although men and women are both vulnerable to the
ramifications of modern lifestyles, accumulating evidence
indicate that CVD affect more women than men.2 This phe-
nomenon is generally attributed to the mounting toll of time
simply because women tend to live longer than men. However,ng by Elsevier B.V. Open access under CC BY-NC-ND license.
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impact of CVD among women is that women usually receive
less aggressive treatment for cardiovascular risk factors, and
are less often referred to cardiac rehabilitation and CVD
prevention programs than men.2,3 Such disparity relative to
sex in patient care may partly be related to the misconception
that women are protected from CVD by estrogen.4 However,
the cardio-protective effects of estrogen erode during meno-
pause.5,6 Many women also tend to express more sedentary
behavior and reduction in leisure-time physical activity as they
move toward and beyond menopause.7,8 Therefore, overweight
and obese women are at high risk to develop CVD as they
advance from middle age to older years.
A recent meta-analysis showed that insulin resistance,
hyperinsulinemia, and hyperglycaemia together with hyper-
triglyceridemia, low high-density lipoprotein cholesterol (HDL-
C) and elevated low-density lipoprotein cholesterol (LDL-C)
and central obesity, are associated with 2-fold increase in car-
diovascular outcomes and a 1.5-fold increase in all-cause
mortality.9 Recent studies have confirmed the benefits of
long-term lifestyle changes on these cardiovascular and meta-
bolic risk factors,10,11 indicating that the impact of lifestyle
decisions on cardiovascular and metabolic health is crucial.
However, whether the benefits of lifestyle modifications on
reducing the risk of CVD are delivered through exercise or
changes in dietary habits is not clear. It also remains to be
determined whether the benefits of exercise and dieting on
cardio-metabolic health are visible in the short-term. To address
these questions we used nuclear magnetic resonance (NMR)-
based metabolic profiling technologies for acquiring high
throughput “snap shots” of a whole organism’s status12 allow-
ing the study of the molecular response to exercise and dieting.
The objective of this study was to compare the effect of 6
weeks short-term moderate intensity aerobic exercise program
and diet counseling on cardio-metabolic risk factors and serum
metabonomics in previously sedentary pre-menopausal over-
weight and obese women.
2. Materials and methods2.1. Ethical approvalThe study protocol was approved by the Ethical Committee
of Central Finland Health Care District. Written informed
consents were obtained from all subjects prior to the
assessments.2.2. Study designThe study subjects were recruited from Jyva¨skyla¨ Central
Finland Health District/Health Promotion Hospital initiative
program. The study was conducted from May to November in
2009. One hundred and sixty-one women (all hospital staff)
responded to our invitation. Sample size was estimated for
different purposes on the primary outcome of the study results
(such as physical fitness measured by walking test and
maximum oxygen uptake (VO2max), heart rate (HR)variability, and insulin resistance). All the sample sizes will
have 85% power to detect differences with p < 0.05 two-sided
significance level. Taking into account the compliance and
drop-out (10%), the total number of subjects was estimated to
meet each specific aims. One hundred met the screening
criteria and were invited by phone or e-mail to participate in
baseline measurements. A physician examined the physical
condition of the subjects and ensured that subjects meet the
inclusion criteria: 20e50 years old pre-menopausal woman
with a body mass index (BMI) between 25 and 38 kg/m2 who
participated regular exercise 2 times/week and 45 min/
time, and had no serious cardiovascular or musculoskeletal
problems, no diagnosed type I diabetes, and had not lost or
gained more than 5 kg in weight during the previous 6 months.
The eligible participants were randomized into parallel exer-
cise (EX) or diet intervention (DI) groups after being enrolled
to the study and the qualification being checked. A computer
program (http://www.random.org/) was used to generate the
random number by blocks (50 numbers in each block). The
randomized number was assigned to the subjects according to
the order of enrollment. The randomization was done by a
researcher that was blinded during the trial and was unblinded
at the conclusion of the trial. All main investigators in the
project were also blinded until the end of the intervention. The
flow chart of the study participants is given in Fig. 1. Ninety
women started intervention (n ¼ 45 in the exercise group (EX)
and n ¼ 45 in the diet group (DI)). Eighty-three women
completed the 6-week intervention and had follow-up mea-
surements (39 in the EX and 44 in the DI). The study was
registered in International Standard Randomized Controlled
Trial Number Register (ISRCTN87529813). Full trial protocol
is available online (http://www.controlled-trials.com/
ISRCTN87529813/87529813).2.3. Background information and anthropometricsBackground information including medical history and
current health status was collected via self-administered
questionnaires. Food consumption and intakes of total en-
ergy and energy-yielding nutrients were assessed from 3-day
food records at baseline and at the end of the study and
analyzed using Micro-Nutrica software developed by the So-
cial Insurance Institution of Finland and updated with data for
new foodstuffs by the study nutritionist.13
Height was determined using a wall-fixed measuring device,
and body mass using a calibrated scale, and from these BMI,
which is expressed as (weight (kg)/height2(m2)), was calculated.
Body compositionwas assessed using a bioelectrical impedance
analysis device (Inbody 720; BiospaceCo. Ltd., Seoul, Republic
of Korea). Inbody is a multifrequency impedance plethysmo-
graph body composition analyzer, which takes readings from the
body using an 8-point tactile electrode method. It measures the
resistance at five specific frequencies (1 kHz, 50 kHz, 250 kHz,
500 kHz, and 1MHz) and reactance at three specific frequencies
(5 kHz, 50 kHz, and 250 kHz). Total body water (TBW) was
estimated from area, volume, length, impedance, and a constant
proportion (specific resistivity). Fat free mass (FFM) was
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calculated by subtracting the FFM from the body weight. Pre-
cision of the repeated measurements of FM expressed as coef-
ficient of variation was on average 0.6%. Subjects were
measured in the morning after 12-h fasting. Before the mea-
surement, subjects were asked to excrete and refrain from
drinking excessive amounts of water.2.4. Blood samplesVenous blood samples for biochemical analyses were taken
in standardized fasting conditions in the mornings betweenFig. 1. Flow-chart of the study participants.7:00 am and 9:00 am before and after intervention. Serum
samples were stored frozen at 80 C until analyzed. Serum
concentrations of glucose, total and HDL cholesterol, tri-
acylglycerol, and non-esterified fatty acids (NEFA) were
analyzed using the KONELAB 20XTi analyzer (Thermo
Fischer Scientific Inc., Waltham, MA, USA). LDL cholesterol
was calculated using the Friedewald equation.14 Serum fasting
insulin concentrations were analyzed using the IMMULITE
1000 analyzer (Siemens Healthcare diagnostics, Mannheim,
Germany). The homeostasis model assessment of insulin
resistance (HOMA-IR) index was calculated as (fasting insulin
concentration  fasting glucose concentration)/22.5.15 Serum
leptin and adiponectin were measured by ELISA (DuoSet;
R&D Systems, Minneapolis, MN, USA). The interleukin-6
(IL-6) and interleukin-8 (IL-8) concentrations were
measured from the serum samples using Cytokine Bead Array
(CBA) Flex Sets kit (BD Biosciences, San Diego, CA, USA)
and a flow cytometer (FACSCalibur; BD Biosciences) ac-
cording to the manufacturer’s instructions. The data were
analyzed by using FCAP Array software (BD Biosciences).
All measurements were performed after 12 h fasting at base-
line and 7 days after the last training session to minimize any
acute effects of exercise.2.5. Serum NMR metabonomicsAll serum samples were analyzed using a high-throughput
serum NMR metabonomics platform; the experimental pro-
tocols including sample preparation and NMR spectroscopy
have been described in detail elsewhere.12,16,17 This platform
provides comprehensive quantitative information on lipopro-
tein subclass concentrations, low-molecular-weight metabo-
lites such as amino acids, ketone bodies, and gluconeogenic
intermediates and detailed molecular information on serum
lipids including, e.g., U-3 and U-6 fatty acids. This platform
has recently been applied in various large-scale epidemiolog-
ical and genetic studies.18e212.6. Fitness testVO2max (mL/kg/min) was assessed by a bicycle ergometer
under the supervision of a physician. The test began with a
2-min warm-up at 50 W. After that the intensity was increased
by 25 W at 2-min intervals until exhaustion. Electrocardiog-
raphy was monitored and continuously and HR and maximal
work load were recorded at the end of every load. Oxygen
uptake was assessed by breath-by-breath method using respi-
ratory gas analyzer (Sensor Medics Vmax, Yorba Linda, CA,
USA). Maximal oxygen uptake was reached, when measured
VO2 reached a plateau or started to decrease or subject felt she
had reached her maximal level and wanted to stop the test.2.7. Exercise programNordic walking (walking with poles) was chosen as the
intervention exercise. A specific training program was devel-
oped after baseline assessments on the basis of each individual’s
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program was progressive based on the recommendation for
sedentary adults. For intervention week 1, the intensity of ex-
ercise was 60% of maximum HR, for 60 min per session and 3
times a week; for intervention weeks 2 and 3 the intensity of
exercise was 65% of maximum HR for 45 min per time and 4
times a week; for intervention weeks 4 and 5, the intensity of
exercise was 70% of maximum HR for 35 min per session and 4
times a week; and for intervention week 6, the intensity of ex-
ercise was 75% of maximum HR for 30 min per session and 3
times a week. Nordic walking was supervised at the beginning
of the intervention (week 1). From week 1 onwards subjects
followed the daily guidance of the wrist computer (Suunto Oy;
Fitness line, Vantaa, Finland) to exercise 30min to 1 h a time and
gradually increase the intensity and duration and participated in
supervised exercise sessions twice per week.2.8. Dietary interventionThe DI group received dietary instruction from a clinical
nutritionist according to the guidelines of Finnish nutrition
recommendations targeting to lose 3 kg of body weight in 6
weeks (National Nutrition Council 2005). The instruction
included controlling energy intake by reducing portion size
using the plate model; controlling meal rhythm and regular
eating between 3 and 4 h intervals; changing the composition
of food stuffs including using light margarine (less than 40%
fat) and vegetable oils, low-fat milk products, low-fat meat
products and fish, light bakery products, increasing fiber intake
using whole-wheat products, vegetables, root vegetables,
berries, fruits, and avoiding products rich in sugar; drinking
1.5e2 L of water per day, mineral water, mild juices, light
beverages, coffee, and tea, and moderating alcohol consump-
tion, preferably of mildly alcoholic drinks only. In addition,
subjects in the DI group were instructed to maintain their
habitual physical activity but no specific exercise program was
provided during the intervention.2.9. Statistical analysesAll data were checked for normality using
the ShapiroeWilk’s W test in SPSS 20 for Windows (SPSS
Inc., Chicago, IL, USA). If data were not normally distrib-
uted, a natural logarithm transform was applied. An
intention-to-treat (ITT) analysis was performed to compare
the EX to the DI group. The effects of the interventions were
assessed using analysis of covariance (ANCOVA) for
repeated measures (treatment group  time) with baseline
values as a covariate. In addition to the ITT analysis, efficacy
analysis was performed. Among the 83 women who had both
baseline and follow-up assessments, 21 were excluded from
the efficacy analysis due to the following reasons: in EX
group, not completing at least 70% of exercise training
(n ¼ 5), and more than 2 weeks delay in participating in the
follow-up assessments (n ¼ 3); in the DI group, flu or other
illness (n ¼ 7) and more than 2 weeks delay in participating
in the follow-up assessments (n ¼ 6) (Fig. 1). The percentagechanges from baseline to follow-up were calculated and the
comparison of percentage changes in different groups was
performed using t tests. The data were presented as
mean  SD. The level of statistical significance chosen for
the comparisons was p < 0.05.
3. Results
At baseline, the DI group weighed more, had greater fat
mass, visceral fat area, BMI, and leptin compared to the EX
group (all p < 0.05, Table 1). The DI group also had higher
a-1-acid glycoprotein, pyruvate, isoleucine, leucine, phenyl-
alanine, and tyrosine levels at baseline (all p < 0.05, Table 2).
No differences in serum lipids, glucose, cytokines, aerobic
fitness, or dietary intake between groups were found.3.1. Intention to treatAfter 6 weeks intervention serum free fatty acids, glucose
and HOMA-IR were significantly reduced in the EX group
compared to the DI group ( p < 0.05 for all, Table 1). No
significant differences (group by time interaction) in body
weight, fat mass, visceral fat area and BMI were observed.
Serum acetate and pyruvate decreased and lactate, glutamine,
lactate to pyruvate ratio, U-3 fatty acids, polyunsaturated fatty
acids and DHA increased in the DI group but not in EX group
with time, and did not show significant group-by-time differ-
ences, except for glutamine and lactate to pyruvate ratio
( p ¼ 0.041 and p ¼ 0.007, Table 2). Tyrosine increased in the
EX group but not in the DI group with time while phenylal-
anine, histidine, glycine, and a-1-acid glycoprotein increased
significantly in both groups over time, but no significant group
by time differences were found.3.2. Efficacy analysisBody weight decreased (on average 1 kg) significantly in
the DI group compared to the EX group ( 1.2%, p < 0.05,
Fig. 2), while significant reduction (group-by-time) in serum
free fatty acids (27.6%, p < 0.001), glucose (11.1%,
p < 0.001), and HOMA-IR (21.2%, p ¼ 0.021) was observed
in the EX group (Fig. 3). DHA (26.3%, p ¼ 0.001) and lactate
to pyruvate ratio (23%, p ¼ 0.003) increased significantly in
the DI group compared to the EX group (Fig. 4).
4. Discussion
The main findings of this study were that 6 weeks of
moderate intensity aerobic exercise in previously sedentary
overweight and obese premenopausal women was associated
with significant reductions in serum free fatty acid, glucose,
and HOMA-IR, without change in body weight, while 6 weeks
of dietary counseling resulted in a small degree of weight loss
with no observable improvements in glucose or lipid
metabolism.
Lifestyle interventions have been shown to be useful
tools in treating cardio-metabolic disorders in pre-
Table 1
Subject characteristics at baseline and after intervention (intention-to-treat) (mean  SD).
Variable EX (n ¼ 39) DI (n ¼ 44) DEX vs. DDI p
Baseline Follow-up Baseline Follow-up
Anthropometry
Age (year) 41.9  7.3 e 42.2  7.5 e e
Height (cm) 166.0  6.2 e 164.4  6.7 e e
Weight (kg) 78.5  8.1 78.3  8.1 85.5  11.3a 84.5  11.1z NS
Fat mass (kg) 28.3  6.0 28.4  5.6 33.6  7.8a 33.2  7.5 NS
VFA (cm2) 120.3  18.2 117.8  18.5 127.1  21.0a 124.6  20.3y NS
Fat free mass (kg) 50.2  5.2 49.9  5.4 51.9  5.9 51.3  5.8y NS
BMI (kg/m2) 28.4  2.1 28.3  2.1 31.3  3.1a 30.8  3.3z NS
Metabolic
GLUC (mmol/L) 5.2  0.5 4.7  0.7y 5.3  0.6 5.4  0.7 <0.001
INS (mU/L) 8.3  4.5 6.7  2.8* 9.5  5.8 8.5  4.8 NS
HOMA-IR 1.8  1.0 1.3  0.6y 2.0  1.0 1.9  1.0 0.010
CHOLtot (mmol/L) 4.9  0.7 5.0  0.8 5.4  0.8 5.6  0.9 NS
LDL (mmol/L) 2.6  0.7 3.1  0.7 3.0  0.6 3.4  0.7 NS
HDL (mmol/L) 1.5  0.3 1.6  0.4 1.4  0.3 1.4  0.4 NS
FFA (mmol/L) 465  201 306  94z 485  160 421  164 <0.001
Trigly (mmol/L) 1.2  0.4 1.2  0.4 1.4  0.6 1.4  0.5 NS
Leptin (ng/mL) 47.5  21.1 44.4  20.5 55.5  20.2a 48.4  22.1y NS
Adiponectin (mg/mL) 7.9  3.1 8.5  3.0 7.1  3.7 8.1  4.1y NS
IL-6 (pg/mL) 4.9  0.5 5.2  0.8 5.0  0.8 5.2  0.7 NS
IL-8 (pg/mL) 9.6  2.0 9.3  2.5 9.7  2.2 9.4  2.1 NS
Diet
Energy (kcal/day) 1724  465 1644  339 1779  465 1656  314 NS
Protein (E%) 18.3  4.2 18.1  2.5 19.1  2.7 17.7  2.2 NS
Fat (E%) 34.1  9.1 34.2  4.5 32.5  7.9 32.8  4.3 NS
Carbohydrate (E%) 45.4  7.9 45.6  5.3 47.5  9.3 47.3  4.7 NS
Fitness
VO2max (mL/kg/min) 32.2  4.9 32.5  5.2 30.4  5.5 31.6  4.7 NS
*p < 0.05, yp < 0.01, zp < 0.001, compared to baseline within group; ap < 0.05, compared to EX baseline.
Abbreviations: VFA ¼ visceral fat area; BMI ¼ body mass index; GLUC ¼ fasting glucose; INS ¼ insulin; HOMA-IR ¼ homeostasis model assessment of insulin
resistance; CHOLtot ¼ total cholesterol; LDL ¼ low density lipoprotein; HDL ¼ high density lipoprotein; FFA ¼ free fatty acids; VO2max ¼ maximum oxygen
uptake; EX ¼ exercise group; DI ¼ diet group; D ¼ change; NS ¼ not significant.
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research on the effects of hormone replacement therapy
(HRT) and exercise on CVD risk factors in healthy post-
menopausal women show that exercise and HRT have both
independent and complimentary effects on body composi-
tion and serum lipid profiles.25e27 The discrepancy may be
due to differences in the type, amount and intensity of ex-
ercise and low sample sizes.28 Nevertheless, recent studies
suggest that with regard to lifestyle interventions, the
greatest benefits arise from combined programs of exercise
and dieting for both pre-29,30 and post-menopausal
women.31,32 These health benefits seem to be attributed to
weight loss achieved in the course of several months or
years.33,34 In the present study, DI group failed to achieve
the targeted reduction of 3 kg of body weight in 6 weeks. As
a result, no significant improvements in cardio-metabolic
risk factors were observed, suggesting that lifestyle inter-
vention using only dietary approaches may need consider-
ably more significant energy restriction and longer duration
in order to induce favorable changes in body weight and
cardio-metabolic health. Exercise training, however, resul-
ted in significant reduction in free fatty acids, glucose, and
HOMA-IR in the absence of weight loss.These findings are in agreement with a previous study
that showed short-term (4 weeks) aerobic exercise decreased
circulating free fatty acids without weight loss in previously
sedentary obese men and pre-menopausal women.35 In that
study, significant decrease in hepatic and visceral lipids was
also observed, indicating that short-term aerobic exercise
can mitigate cardiovascular risk and this is not contingent
upon weight loss. In the present study, we did not measure
hepatic content but exercise training tended to result in
reduction in visceral fat. Therefore, we cannot rule out that
reduction in hepatic and visceral fat may have contributed to
the reduction of free fatty acids, glucose, and insulin resis-
tance in the EX group. However, dieting resulted in reduc-
tion in visceral fat without concurrent changes in either lipid
or glucose metabolism. These observations do not support
the notion that reduction in free fatty acids and insulin
resistance within EX group was attributed to reduction of
visceral fat.
To delineate the metabolic shifts underlying our observa-
tions we performed NMR-based serum metabolomics analysis.
However, given the significant reduction in serum fatty acids
and glucose in the EX group, surprisingly subtle changes were
observed in serum metabolites levels. No change in leptin or
Table 2
Serum low-molecular-weight metabolites and lipid constituents at baseline and after intervention (intention-to-treat) (mean  SD).
Variable EX (n ¼ 39) DI (n ¼ 44) DEX vs. DDI p
Baseline Follow-up Baseline Follow-up
Low-molecular-weight metabolites
3-HB 0.09  0.05 0.10  0.03 0.10  0.03 0.11  0.03 NS
Acetate 0.08  0.01 0.08  0.01 0.08  0.01 0.07  0.01* NS
Acetoacetate 0.08  0.01 0.06  0.03 0.05  0.02 0.06  0.02 NS
Lactate 1.10  0.27 1.22  0.50 1.21  0.32 1.38  0.41* NS
Leucine 0.10  0.02 0.10  0.01 0.10  0.02a 0.10  0.01 NS
Isoleucine 0.06  0.01 0.06  0.01 0.06  0.01a 0.07  0.01 NS
Valine 0.22  0.03 0.23  0.03 0.22  0.04 0.23  0.03 NS
Alanine 0.45  0.06 0.46  0.07 0.47  0.06 0.48  0.06 NS
Glutamine 0.53  0.07 0.54  0.06 0.52  0.09 0.57  0.08z 0.041
Phenylalanine 0.08  0.01 0.09  0.01y 0.08  0.01a 0.09  0.01y NS
Tyrosine 0.05  0.01 0.06  0.01* 0.06  0.01a 0.07  0.01 NS
Histidine 0.07  0.01 0.08  0.01* 0.07  0.01 0.08  0.01y NS
Pyruvate 0.09  0.04 0.10  0.03 0.12  0.03a 0.10  0.05* NS
Citrate 0.09  0.01 0.09  0.01 0.09  0.01 0.09  0.01 NS
Creatinine 0.06  0.01 0.06  0.01 0.06  0.01 0.07  0.01 NS
Glycine 0.29  0.07 0.31  0.06y 0.31  0.05 0.32  0.06* NS
Glycerol 0.08  0.02 0.09  0.03 0.09  0.03 1.00  0.03 NS
a-1-acid glycoprotein 1.79  0.19 1.87  0.21y 1.89  0.25a 2.02  0.23y NS
3-HB/aceA 1.86  0.46 1.83  0.40 1.88  0.53 2.00  0.57 NS
Lactate/pyruvate 13.9  6.7 13.0  6.8 11.3  4.6 18.2  12.6z 0.007
Lipid exctract constituents
E-chol 3.6  0.6 3.7  0.7 3.8  0.5 3.9  0.7 NS
F-chol 1.4  0.2 1.4  0.2 1.5  0.2 1.5  0.3 NS
U-3 fatty acids 0.4  0.1 0.4  0.1 0.4  0.1 0.5  0.2* NS
U-6 fatty acids 3.6  0.6 3.6  0.5 3.7  0.5 3.8  0.6 NS
U-7, 9 fatty acids 7.2  1.9 7.3  1.9 7.4  1.5 7.8  2.0 NS
Linoleic acid 3.1  0.6 3.2  0.4 3.2  0.5 3.3  0.6 NS
DHA 0.18  0.06 0.19  0.06 0.17  0.05 0.21  0.08z NS
PUFA 2.0  0.5 2.1  0.5 2.1  0.4 2.3  0.6y NS
MUFA 3.4  1.0 3.5  1.0 3.6  0.9 3.7  1.0 NS
PGtot 0.9  0.2 0.9  0.2 0.9  0.2 1.0  0.2 NS
PCtot 2.2  0.4 2.2  0.4 2.3  0.3 2.3  0.4 NS
SPH 0.40  0.05 0.40  0.05 0.40  0.06 0.40  0.07 NS
*p < 0.05, yp < 0.01, zp < 0.001, compared to baseline within group; ap < 0.05, compared to EX baseline.
Note: Metabolite concentrations are in mmol/L unless stated otherwise.
Abbreviations: 3-HB ¼ 3-hydroxybutyrate; 3-HB/aceA ¼ 3-hydroxybutyrate to acetoacetate ratio; E-chol ¼ esterified cholesterol; F-chol ¼ free cholesterol;
DHA ¼ docosahexaenoic acid; PUFA ¼ polyunsaturated fatty acids; MUFA ¼ monounsaturated fatty acids; PGtot ¼ total phosphoglycerides; PCtot ¼ total
phosphatidylcholines; SPH ¼ sphingomyelines; EX ¼ exercise group; DI ¼ diet group; D ¼ change; NS ¼ not significant.
Fig. 2. Mean changes of body composition (efficacy analysis) in women in the
exercise (n ¼ 31, solid line) and dietary counseling (n ¼ 31, dotted line)
groups. Squares represent mean values and lines indicate 95% confidence
interval. *p < 0.05, compared to diet group.
Fig. 3. Mean changes of metabolic measures (efficacy analysis) in women in
the exercise (n ¼ 31, solid line) and dietary counseling (n ¼ 31, dotted line)
groups. Squares represent mean values and lines indicate 95% confidence
interval. *p < 0.05, zp < 0.001, compared to diet group. FFA ¼ free fatty
acids; CHOLtot ¼ total cholesterol; LDL ¼ low density lipoprotein;
HDL ¼ high density lipoprotein.
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Fig. 4. Mean changes of serum metabolites (efficacy analysis) in women in the
exercise (n ¼ 31, solid line) and dietary counseling (n ¼ 31, dotted line).
Squares represent mean values and lines indicate 95% confidence interval.
*p < 0.05, yp < 0.01, compared to exercise group. 3-HB ¼ 3-hydroxybutyrate;
3-HB/aceA ¼ 3-hydroxybutyrate to acetoacetate ratio; E-chol ¼ esterified
cholesterol; F-chol ¼ free cholesterol; DHA ¼ docosahexaenoic acid;
PUFA ¼ polyunsaturated fatty acids; MUFA ¼ monounsaturated fatty acids.
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training, whilst dieting significantly decreased leptin and
increased adiponectin levels, indicating that the reduction in
serum glucose and free fatty acids did not result from insulin
sensitizing effects of adipokines.36 Exercise training was not
associated with changes in beta hydroxybutyrate to acetoace-
tate ratio or lactate to pyruvate ratio which are indicators of
redox state in mitochondria,37 suggesting that the beneficial
effects of aerobic exercise on glucose and lipid metabolism
was not ascribed to reduced reactive oxygen species produc-
tion. Exercise resulted in increased serum phenylalanine and
glycine and, to a lesser significant extent, tyrosine and histi-
dine concentrations. Increased levels of serum phenylalanine
and tyrosine have been associated with obesity and insulin
resistance in previous studies,38 whereas increased serum
glycine has been associated with increased insulin sensitivity
and fatty acid oxidation.39 Thus, reductions in insulin resis-
tance and serum free fatty acids in the EX group may have
resulted from recovery of serum glycine concentrations andsubsequent increase in mitochondrial function. Moreover, it
has been shown that, in sedentary subjects, greater metabolic
stress results in adaptation manifested by improved muscular
mitochondrial biogenesis and enhanced fatty acid oxidation,40
which thereby may accelerate fatty acid removal from circu-
lation.41 Therefore, it is plausible that the mitochondrial
adaptation to progressive exercise training was responsible for
the reduction in free fatty acids and the subsequent reduction
in insulin resistance in the present study.
The strength of our randomized trial study design reached the
methodological requirements of physical activity trials42 to pro-
vide reliable and valid evidence on the effects of exercise. Our
design also focused on moderate progressive aerobic exercise
training because this is what is recommended in most public
health guidelines for adults.43 All the samples were analyzed in
the same laboratory at the same time by a same person. However,
the current study is limited by the homogeneous subjects con-
sisting Finnish women. Therefore, our results may not be trans-
ferrable to the general population. The fact that we used
bioimpedance instead of dual-energy X-ray absorptiometry or
magnetic resonance imaging to define body composition may
predispose our results to measurement error.44 Furthermore,
VO2max was defined by bicycle ergometer, while exercise training
consisted ofNordicwalking. Thismaywell account for the failure
to detect significant changes in aerobic fitness by VO2max test.
5. Conclusion
The results of the current study show that small weight loss
induced by dieting does not produce measurable health benefits
in serum level, whereas short-term regular aerobic exercise can
improve glucose and lipid metabolism even in the absence of
weight loss in previously sedentary overweight and obesewomen.
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